Terns Pharmaceuticals' obesity drug cuts weight by 4.9% in early study

Terns Pharmaceuticals

09/09/2024 12:13

Sept 9 (Reuters) - Terns Pharmaceuticals  TERN.O  said
on Monday its experimental obesity drug helped to significantly
reduce weight by an average of 4.9% compared to placebo in an
early-stage study.

 (Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi
Majumdar)
 ((Mariam.ESunny@thomsonreuters.com))